Biomarin Pharmaceutical – Investors and Politicians Who Own It

BMRN, 6 share classes and securities

Investors who own it

7 tracked investors, $1.5B in shares, each from their latest 13F.

InvestorValueShare of portfolio
$849.4M0.44%
Andreas HalvorsenViking Global Investors, Q2 2026
$435.8M1.24%
David KroinDeep Track Capital, Q2 2026
$189.3M2.75%
Howard MarksBondOaktree Capital Management, Q2 2026
$62.4M0.87%
Ray DalioBridgewater Associates, Q2 2026
$15.7M0.06%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$2.8M0.13%
Mario GabelliGAMCO Investors, Q2 2026
$743.9K0.01%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

No member of Congress is estimated to hold this stock.

InvestorActionShares now
Behzad AghazadehReduced −55%2,038,015
Dodge & CoxReduced −0.2%13,898,318
Andreas HalvorsenAdded +38%9,753,293
Anand ParekhSold out0
George SorosSold out0
Ray DalioAdded +307%142,314
National Pension Service (Korea)Added +4.2%345,387
Howard MarksBondSold out0
Daniel SchneebergerCallNew5,000
Daniel SchneebergerNew1,200
Mario GabelliAdded +24%6,565

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

PoliticianActionTraded
Daniel S. GoldmanD-NY · House
Sold$1K–$15KMar 6, 2023disclosed Apr 17, 2023
Josh GottheimerJointD-NJ · House
Sold$1K–$15KOct 18, 2021disclosed Nov 15, 2021
Bought$15K–$50KDec 30, 2020disclosed Jan 11, 2021
Josh GottheimerJointD-NJ · House
Bought$1K–$15KOct 16, 2020disclosed Nov 5, 2020
Josh GottheimerJointD-NJ · House
Sold$1K–$15KSep 15, 2020disclosed Oct 13, 2020
Josh GottheimerJointD-NJ · House
Bought$1K–$15KDec 16, 2019disclosed Jan 6, 2020
Josh GottheimerJointD-NJ · House
Bought$1K–$15KDec 11, 2019disclosed Jan 6, 2020